Resonant Clinical Solutions
Resonant Clinical Solutions is a global life science services company providing clinical trial kitting, equipment management, and biorepository storage to biotech, pharmaceutical, and diagnostic laboratory customers across the US and Europe. The PE-backed platform operates through legacy brands Therapak, MESM, and EPL Archives.
- Company typePrivate
- Founded1984
- HeadquartersClaremont, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What Resonant Clinical Solutions does
Resonant Clinical Solutions is a global life science solutions company providing clinical trial and diagnostic supply chain services across three integrated service lines: Kitting by Therapak, Equipment & Ancillaries by MESM, and Biorepository by EPL Archives. The company serves 500+ customers spanning biotech and pharmaceutical companies, contract research organizations, and diagnostic laboratories, with claimed coverage of 100% of the top 10 global biopharma companies and support for 2,500+ clinical trials. Operational infrastructure includes over 850 employees and 3M+ cubic feet of temperature-controlled storage capacity (ranging from -196°C cryogenic to +21°C ambient) across facilities in Claremont (headquarters), Leesburg/Sterling (US), Frankfurt, and Carros, France, with all sites certified to GLP, GxP, cGMP, IATA, and OECD standards.
The business operates on a professional services and managed services revenue model, combining customized kitting solutions (kits ranging from 1 to 10,000+ units), end-to-end equipment lifecycle management (sourcing through removal), and long-term biorepository archiving from preclinical through post-trial phases. Go-to-market is enterprise field sales supported by proprietary client portals (PASSPORT and LabTrak) that provide order management, tracking, and traceability. Pricing is not publicly disclosed and is quote-based, consistent with custom clinical trial and lab service contracts. Customer tenure averages 10+ years in the diagnostic lab segment, and overall retention stands at 90%.
The company was founded in 1984, acquired by Audax Private Equity from Avantor in 2024, and appointed Christophe Berthoux as CEO in June 2025 to lead its next phase of growth. Under Audax ownership, the company is positioned as a stand-alone platform with stated intent to expand capabilities, customer base, and geographic reach through organic investment and potential inorganic moves, leveraging the new CEO's prior track record of M&A-driven scaling at NAMSA, Synexus, CitoxLab, and Charles River Laboratories.
Resonant Clinical Solutions firmographics
Firmographics- Name
- Resonant Clinical Solutions
- Legal name
- Resonant Clinical Solutions
- Website
- https://resonantclinical.com
- Company type
- Private
- Founded year
- 1984
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Resonant Clinical Solutions is a global life science services company providing clinical trial kitting, equipment management, and biorepository storage to biotech, pharmaceutical, and diagnostic laboratory customers across the US and Europe. The PE-backed platform operates through legacy brands Therapak, MESM, and EPL Archives.
- Ownership category
- akta.pro rank
Resonant Clinical Solutions industry classification
Industry- Product category
- Clinical Trial Supply Chain Services
- NAICS
- Scientific Research and Development Services (5417), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI)
- akta.pro secondary industries
- Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)
Keywords
Where Resonant Clinical Solutions is headquartered
LocationHeadquarters
- HQ city
- Claremont
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
Resonant Clinical Solutions business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Kitting Services: Customized clinical trial and diagnostic lab kitting solutions delivered on time and in full to locations worldwide
- Equipment & Ancillaries Services: End-to-end global equipment management including sourcing, delivery, calibration and removal through the equipment lifecycle
- Biorepository & Archiving Services: Comprehensive biological storage, archiving and data management services covering the entire clinical trial storage continuum from preclinical through post-trial
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Resonant Clinical Solutions product offering
Product offeringCore offering
Resonant Clinical Solutions delivers customized clinical trial and diagnostic lab kitting, end-to-end global equipment lifecycle management, and temperature-controlled biorepository storage and archiving services. The company combines three legacy brands—Therapak (kitting), MESM (equipment), and EPL Archives (biorepository)—into an integrated supply chain offering for biotech, pharmaceutical, CRO, and diagnostic lab customers operating clinical and diagnostic programs globally.
Product overview
Resonant Clinical Solutions operates as a unified platform offering three core service lines—Kitting by Therapak, Equipment & Ancillaries by MESM, and Biorepository by EPL Archives—along with specialized sub-services including Storage & Facilities, Archiving Services, and Sample Processing. The company provides clinical trial supply chain and laboratory supply chain services to pharmaceutical and biotechnology companies, contract research organizations (CROs), and diagnostic laboratories.
Differentiator
Problem solved
Functional benefit
Brands
- Therapak: Kitting services - provides complete, customized kitting solutions for laboratory and research partners
- MESM
- EPL Archives
Products and services
- Kitting by Therapak Complete, fully customizable clinical trial and diagnostic lab kitting solutions delivered on time and in full to locations worldwide, featuring validated packaging that maintains sample integrity from collection through arrival. Targeted at biotech and pharmaceutical companies, contract research organizations, and diagnostic laboratories running clinical and diagnostic programs.
- Equipment & Ancillaries by MESM End-to-end global equipment management solution spanning sourcing, delivery, calibration, and removal, with service and support throughout the equipment lifecycle. Targeted at biotech, pharmaceutical, and diagnostic lab customers managing laboratory and clinical trial equipment needs.
- Biorepository by EPL Archives Temperature-controlled biorepository facilities positioned globally, covering complete biological storage, archiving, and data management needs from preclinical through post-trial phases, with regulatory compliance and chain-of-custody transparency. Targeted at biotech, pharmaceutical, CRO, and diagnostic lab customers needing long-term clinical trial and diagnostic sample management.
- Storage & Facilities Global network of temperature- and humidity-controlled storage facilities with over 3 million cubic feet of capacity, maintaining samples from -196°C to +21°C, with real-time visibility and 24-hour asset retrieval capabilities. Targeted at clinical trial and diagnostic lab customers requiring compliant, multi-temperature biological storage.
- Archiving Services GxP-compliant biostorage facilities purpose-built and equipped to meet strictest QA audit standards, flexibly managing requirements through the research lifecycle from preclinical studies to post-commercial research. Targeted at biotech, pharma, and CRO customers with long-term sample retention obligations.
- Sample Processing Precision aliquoting services delivering accuracy down to the microliter, with full audit trails, rapid turnaround, and seamless storage or global dispatch, including collection, precision aliquoting, and digital services. Targeted at clinical trial and diagnostic lab customers needing accurate, compliant sample processing.
Quantifiable outcome
- 90% customer retention rate demonstrating service quality and reliability
- +6 more outcomes
Companies that use Resonant Clinical Solutions
Customer profileNamed customers9 records
Segments2 records
Ideal customer profiles2 records
Resonant Clinical Solutions technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Resonant Clinical Solutions partnerships and signals
Strategic signalScale indicators13 records
Recent moves5 records
Expansion highlights5 records
Resonant Clinical Solutions competitors and assessment
Company assessmentDirect peers
- Azenta Life Sciences: Azenta (formerly Brooks Life Sciences) is a direct peer, providing automated sample management, biorepository storage, and cold-chain logistics for clinical and research samples. Overlaps directly with Resonant's EPL Archives biorepository line and sample processing services.
- Marken (UPS Healthcare): Marken, the clinical trial logistics arm of UPS Healthcare, is a direct peer in clinical trial kit production, sample logistics, and cold-chain distribution. Competes head-to-head with Resonant's Therapak kitting and global equipment/lifecycle services.
Broad incumbents
- Thermo Fisher Scientific (Clinical Services): Thermo Fisher's PPD clinical research and Fisher Clinical Services divisions compete across clinical trial supplies, central labs, and biorepository. Much larger, but overlaps meaningfully with all three of Resonant's service lines.
- Charles River Laboratories: Charles River offers end-to-end preclinical and clinical lab services including biorepository and sample management. Resonant's new CEO was previously CCO at Charles River, reflecting the strong operational overlap and the competitive context for Resonant's services.
- IQVIA: IQVIA is a global CRO and clinical services platform with embedded clinical trial supply, lab, and data services. As sponsors consolidate to mega-vendors, IQVIA represents both a customer-relationship risk and a competitor in integrated trial supply.
- Eurofins Scientific: Eurofins operates a global network of clinical and bioanalytical laboratories with biorepository capabilities. Overlaps with Resonant's diagnostic lab kitting and sample storage services, especially in Europe.
- Avantor: Avantor is the former parent of Resonant (sold to Audax in 2024) and a major life sciences products distributor with biostorage and clinical services capabilities. Continues to operate adjacent offerings that may compete with Resonant in select accounts.
- Fortrea (formerly Labcorp Drug Development): Fortrea is a global CRO spun out of Labcorp in 2023, providing clinical development and central lab services including biorepository. Competes for the same biopharma customers as Resonant for clinical trial sample management.
- Medpace Holdings: Medpace is a mid-sized global CRO serving biopharma, with embedded clinical trial support services. While not a kitting/biorepository specialist, it competes for the same trial services wallet and could disintermediate niche suppliers.
Emerging players
- Cell & Co Bioservices: Cell & Co is a French biorepository and biospecimen provider with BSL-2 capabilities, comparable in scale and focus to Resonant's Carros facility. Represents a regional/emerging competitor in the European sample management niche.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Resonant Clinical Solutions social profiles
Digital presenceResonant Clinical Solutions compliance and trust
Trust signalCompliance6 records
Resonant Clinical Solutions financial estimates
Financial estimateRevenue estimate
Valuation estimate
Resonant Clinical Solutions leadership team
Management profileNumber of profiles
Profiles1 record
Resonant Clinical Solutions funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Resonant Clinical Solutions M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Resonant Clinical Solutions
What does Resonant Clinical Solutions do?
Resonant Clinical Solutions delivers customized clinical trial and diagnostic lab kitting, end-to-end global equipment lifecycle management, and temperature-controlled biorepository storage and archiving services. The company combines three legacy brands—Therapak (kitting), MESM (equipment), and EPL Archives (biorepository)—into an integrated supply chain offering for biotech, pharmaceutical, CRO, and diagnostic lab customers operating clinical and diagnostic programs globally.
Is Resonant Clinical Solutions a public or private company?
Resonant Clinical Solutions is a private company. It is classified as private equity controlled and is currently operating.
When was Resonant Clinical Solutions founded?
Resonant Clinical Solutions was founded in 1984. It employs 501 to 1,000 people.
Where is Resonant Clinical Solutions based?
Resonant Clinical Solutions is headquartered in Claremont, United States, in the North America region.
How does Resonant Clinical Solutions make money?
Three revenue lines are on record. Kitting Services are the primary driver. The others are equipment & Ancillaries Services and biorepository & Archiving Services.
Who are Resonant Clinical Solutions's main competitors?
Direct peers on record are Azenta Life Sciences and Marken (UPS Healthcare). Broad incumbents are Thermo Fisher Scientific (Clinical Services), Charles River Laboratories, IQVIA, Eurofins Scientific, Avantor, Fortrea (formerly Labcorp Drug Development) and Medpace Holdings. Cell & Co Bioservices is listed as an emerging player.
Does Resonant Clinical Solutions have an API?
No public API is recorded for Resonant Clinical Solutions.
What industry is Resonant Clinical Solutions in?
Resonant Clinical Solutions's product category is Clinical Trial Supply Chain Services. Its primary akta.pro industry code is HLAGAEAI, Sample Logistics, Biorepository & IVD Kit Management (Trial Support), with a secondary code of HLAGABAK, Clinical Trial Material (CTM) Manufacturing & Supply CDMO. Its NAICS code is 5417 and its SIC code is 5047.